[
    [
        {
            "time": "2019-04-25",
            "original_text": "Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure",
            "features": {
                "keywords": [
                    "Amgen",
                    "Q1",
                    "Earnings",
                    "Sales",
                    "Pricing Pressure"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-04-26",
            "original_text": "Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice",
            "features": {
                "keywords": [
                    "High-Growth",
                    "Dividend",
                    "Eli Lilly",
                    "Great Choice"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-04-26",
            "original_text": "Eli Lilly misses on revenue in face of pricing pressures and growing generic competition",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "misses",
                    "revenue",
                    "pricing pressures",
                    "generic competition"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly misses on revenue in face of pricing pressures and growing generic competition",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-04-26",
            "original_text": "Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Q1",
                    "2019",
                    "Earnings",
                    "Call",
                    "Transcript"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Eli Lilly and Company (LLY) Q1 2019 Earnings Call Transcript",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-04-25",
            "original_text": "Amgen Reports an Unusual Slide Backward",
            "features": {
                "keywords": [
                    "Amgen",
                    "Unusual",
                    "Slide",
                    "Backward"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Amgen Reports an Unusual Slide Backward",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]